UK MHRA Notes Concern Over Medtech’s Mid-2023 Deadline – But Still No Draft Law Progress

The One Agency initiative, patient safety, methods of funding and recruitment needs were pressing discussion themes during the MHRA’s April 2022 board meeting held in public.

alamy

The UK medtech industry keenly awaits news of any progress by the Medicines and Healthcare products Regulatory Agency (MHRA) on its written response to the UK CA marking consultation, held in autumn 2021.

The agency promised in its delivery plan to lay the new medical device statutory instrument by 31 March 2023, which...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from United Kingdom

More from Europe